368OTumor mutation index as a biomarker for responsive stratification on multi-targeted TKI anlotinib: An ALTER-0303 companion diagnostic study. (25th November 2018) - Lu, J; Zhang, W; Yan, B; Li, H; Zhang, L; Dong, Y; Qian, J; Wang, S; Zhang, B; Wu, J; Zhao, X; Zhao, Y; et al.